Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).

Simple item page
dc.contributor.authorRadzina, Maija
dc.contributor.authorMamis, Edgars
dc.contributor.authorSaule, Laura
dc.contributor.authorPajuste, Elīna
dc.contributor.authorKalniņa, Marika
dc.contributor.authorCocolios, Thomas
dc.contributor.authorTalip, Zeynep
dc.contributor.authorStora, Thierry
dc.date.accessioned2022-10-24T10:35:01Z
dc.date.available2022-10-24T10:35:01Z
dc.date.issued2022-09-30
dc.description.abstractThis document is a summary of responses received from the public known European industrial manufacturing and research institution and clinical facility representatives. The responses were given to the PRISMAP Consortium questionnaire disseminated in January-August 2022, approaching radionuclides and radiopharmaceutical manufacturers, research institutions and clinical end users in nuclear medicine, with the aim to identify potential stakeholders in the industrial and clinical communities interested by a coordinated approach in Europe such as PRISMAP. The summary from PRISMAP questionnaire stratifies the feedback from 114 respondents: radionuclide and radiopharmaceutical producers, research facilities and preclinical/clinical end users. In addition, it gives an insight into the location and capabilities of the main isotope-producing cyclotron facilities, many of which are known from the IAEA cyclotron database [2]). The questionnaire was offered with an opportunity to make new research and international collaboration partners, where all parties could benefit from harmonised supply and legislation procedures, expanding network and distribution routes, and subsequently gain visibility within the PRISMAP User Forum map at www.prismap.eu. The questionnaire was focused on the radionuclide use in medicine with emphasis on future needs for specific radionuclides and possible research developments with awareness of legislation, logistics and involved personnel education challenges and future perspectives.en
dc.description.statusPeer reviewed
dc.format.extent60
dc.format.extent7469821
dc.identifier.citationRadzina, M, Mamis, E, Saule, L, Pajuste, E, Kalniņa, M, Cocolios, T, Talip, Z & Stora, T 2022, Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0). https://doi.org/10.5281/zenodo.7154340
dc.identifier.doi10.5281/zenodo.7154340
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/9672
dc.language.isoeng
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subject3.2 Clinical medicine
dc.subject6. Other publications
dc.titleDeliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/bookanthology/commissioned

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Deliverable_5.1.pdf
Size:
7.12 MB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure